PALATIN TECHNOLOGIES, INC. Shareholders' Equity
PALATIN TECHNOLOGIES, INC. (PTN) had Shareholders' Equity of $10.59 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-13
- 2026-03-31: Stockholders' Equity Attributable to Parent $10.59M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $11.47M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $396.40K.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$4.78M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-03-31 | $10.59M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $11.47M 10-Q · filed 2026-05-13 | |
| 2025-09-30 | $396.40K 10-Q · filed 2026-02-17 | |
| 2025-06-30 | -$4.78M 10-Q · filed 2026-05-13 | |
| 2025-03-31 | -$6.39M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | -$6.38M 10-Q · filed 2026-05-13 | |
| 2024-09-30 | -$7.69M 10-Q · filed 2026-02-17 | |
| 2024-06-30 | -$111.50K 10-Q · filed 2026-05-13 | |
| 2024-03-31 | $1.58M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | -$11.38M 10-Q · filed 2025-05-14 | |
| 2023-09-30 | -$6.32M 10-Q · filed 2025-02-13 | -$4.89M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$1.98M 10-K · filed 2025-09-23 | $134.07K 10-K · filed 2023-09-28 |
| 2023-03-31 | $6.58M 10-Q · filed 2024-05-15 | $9.59M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $11.53M 10-Q · filed 2024-05-15 | $16.34M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $8.45M 10-Q · filed 2024-02-14 | |
| 2022-06-30 | $16.27M 10-K · filed 2024-09-30 | |
| 2022-03-31 | $28.09M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $35.20M 10-Q · filed 2023-05-15 | |
| 2021-09-30 | $42.97M 10-Q · filed 2023-02-14 | |
| 2021-06-30 | $49.65M 10-K · filed 2023-09-28 | |
| 2021-03-31 | $62.88M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $67.84M 10-Q · filed 2022-05-16 | |
| 2020-09-30 | $76.98M 10-Q · filed 2022-02-14 | |
| 2020-06-30 | $80.17M 10-K · filed 2022-09-22 | |
| 2020-03-31 | $86.69M 10-Q · filed 2021-05-14 | |
| 2019-12-31 | $91.37M 10-Q · filed 2021-05-14 | |
| 2019-09-30 | $96.12M 10-Q · filed 2021-02-16 | |
| 2019-06-30 | $100.55M 10-K · filed 2021-09-28 | |
| 2019-03-31 | $16.07M 10-Q · filed 2020-05-11 | |
| 2018-12-31 | $21.14M 10-Q · filed 2020-05-11 | |
| 2018-09-30 | $25.17M 10-Q · filed 2020-02-10 | |
| 2018-06-30 | $26.96M 10-K · filed 2020-09-25 | |
| 2018-03-31 | $10.23M 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $9.63M 10-Q · filed 2019-05-09 | |
| 2017-09-30 | $5.98M 10-Q · filed 2019-02-11 | |
| 2017-06-30 | -$5.16M 10-K · filed 2020-09-25 | |
| 2017-03-31 | -$18.86M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$15.96M 10-Q · filed 2017-02-10 | |
| 2016-09-30 | -$21.77M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$17.59M 10-K · filed 2019-09-12 | |
| 2016-03-31 | -$4.70M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $7.48M 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $20.23M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $12.20M 10-K · filed 2018-09-13 | |
| 2015-03-31 | $23.98M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $32.68M 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $10.80M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $9.79M 10-K · filed 2017-09-25 | |
| 2014-03-31 | $13.99M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $15.26M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $18.67M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $22.98M 10-K · filed 2016-09-19 | |
| 2013-03-31 | $27.60M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $31.46M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $33.00M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.83M 10-K · filed 2015-09-18 | |
| 2012-03-31 | $6.91M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $12.66M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $15.05M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $18.19M 10-K · filed 2013-09-27 | |
| 2010-06-30 | $9.32M 10-K · filed 2013-09-27 | |
| 2009-06-30 | $3.31M 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |